<p>Splenocytes were stained with anti-CD19-eFluor450, anti-CD3-PE, anti-CD11c-APC, anti-CD27-APC-eFluor780 and anti-CD103-FITC prior to sorting on the FACSAria. The plots show sorting on a representative HCLc case. <b>A:</b> displays pre-sorted mononuclear cells, with CD19<sup>+</sup>CD11c<sup>+</sup>CD103<sup>+</sup>CD27<sup>-</sup> HCLc tumour cells 78.0% of sample and CD3+ T cells 3.3%. Cells were initially gated on FSC/SSC (<b>A</b>, left) then either CD3+ for T cells or CD19+ for B cells (<b>A</b>, second left). CD19+ cells were subsequently gated as CD11c+ (<b>A</b>, second right), then CD103+ and CD27- (<b>A</b>, right) to capture high purity HCL cells. In <b>B</b> post-sorted cells were checked for purity: T cells were purified at 9...
Cells collected from ascites were stained with a 9-color flow cytometry panel and analyzed in an X-2...
<p>A: CD4<sup>+</sup>-T cells (P1) were gated by fluorescence intensity of CD4 versus side light sca...
The % of CD3 (CD3+CD19-), the % of CD4 (CD3+CD4+), the % of CD8 (CD3+CD8+) and the % of CD19 (CD3-CD...
Shown are gating strategies for the analysis of (A), human immune cell subsets (hCD45+CD3+: T cells,...
<p>(<b>A</b>) Digested tissue samples were subjected to PI live/dead cell exclusion and CD45<sup>+</...
<p>Analysis following gating: (<b>A</b>) Selection of living mononuclear cells on the histogram with...
Representative plots showing activated B cells (ABC) as CD19+CD10-IgD-CD71+CD38-CD20+ and antibody s...
Splenocytes were collected after 24-hour culture and stained for flow cytometry. Cell singlets were ...
Gating strategies to identification stromal cells (A), resident myeloid cells (B), resident CD4+ and...
Representative plots showing non-circulating T follicular helper cells (cTfh) populations as CD3+CD4...
(A) Lymph node samples were gated for total lymphocytes, singles cells, and live cells. Live cells w...
<p>Flow cytometry gating strategy of Vδ2<sup>+</sup> T cells and FasL expressing Vδ2<sup>+</sup> T c...
Gating strategy for T and B cell panels are shown. Naïve CD4+ or CD8+ T cells were defined as CD28+/...
<p>CD4<sup>+</sup> T cells (B) were gated from lymphocytes (A) for further phenotyping. (C, D, E) Re...
<p>CD4+ T cells are first enriched from draining lymph node cells with untouched paramagnetic bead s...
Cells collected from ascites were stained with a 9-color flow cytometry panel and analyzed in an X-2...
<p>A: CD4<sup>+</sup>-T cells (P1) were gated by fluorescence intensity of CD4 versus side light sca...
The % of CD3 (CD3+CD19-), the % of CD4 (CD3+CD4+), the % of CD8 (CD3+CD8+) and the % of CD19 (CD3-CD...
Shown are gating strategies for the analysis of (A), human immune cell subsets (hCD45+CD3+: T cells,...
<p>(<b>A</b>) Digested tissue samples were subjected to PI live/dead cell exclusion and CD45<sup>+</...
<p>Analysis following gating: (<b>A</b>) Selection of living mononuclear cells on the histogram with...
Representative plots showing activated B cells (ABC) as CD19+CD10-IgD-CD71+CD38-CD20+ and antibody s...
Splenocytes were collected after 24-hour culture and stained for flow cytometry. Cell singlets were ...
Gating strategies to identification stromal cells (A), resident myeloid cells (B), resident CD4+ and...
Representative plots showing non-circulating T follicular helper cells (cTfh) populations as CD3+CD4...
(A) Lymph node samples were gated for total lymphocytes, singles cells, and live cells. Live cells w...
<p>Flow cytometry gating strategy of Vδ2<sup>+</sup> T cells and FasL expressing Vδ2<sup>+</sup> T c...
Gating strategy for T and B cell panels are shown. Naïve CD4+ or CD8+ T cells were defined as CD28+/...
<p>CD4<sup>+</sup> T cells (B) were gated from lymphocytes (A) for further phenotyping. (C, D, E) Re...
<p>CD4+ T cells are first enriched from draining lymph node cells with untouched paramagnetic bead s...
Cells collected from ascites were stained with a 9-color flow cytometry panel and analyzed in an X-2...
<p>A: CD4<sup>+</sup>-T cells (P1) were gated by fluorescence intensity of CD4 versus side light sca...
The % of CD3 (CD3+CD19-), the % of CD4 (CD3+CD4+), the % of CD8 (CD3+CD8+) and the % of CD19 (CD3-CD...